BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4604570)

  • 21. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis.
    Provost TT; Garrettson LK; Zeschke RH; Rose NR; Tomasi TB
    Clin Immunol Immunopathol; 1973 Jul; 1(4):429-45. PubMed ID: 4617643
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapy in recurrent coccidioidomycosis.
    Stevens DA; Pappagianis D; Marinkovich VA; Waddell TF
    Cell Immunol; 1974 Apr; 12(1):37-48. PubMed ID: 4458962
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immunity in patients with amebic abscess of the liver.
    Ortiz-Ortiz L; Zamacona G; Sepúlveda B; Capín NR
    Clin Immunol Immunopathol; 1975 May; 4(1):127-34. PubMed ID: 165023
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 26. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular immune response in coccidioidomycosis.
    Catanzaro A; Spitler LE; Moser KM
    Cell Immunol; 1975 Feb; 15(2):360-71. PubMed ID: 1089482
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of mucocutaneous candidasis with transfer factor.
    Feigin RD; Shackelford PG; Eisen S; Spitler LE; Pickering LK; Anderson DC
    Pediatrics; 1974 Jan; 53(1):63-70. PubMed ID: 4588132
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis].
    Bläker F; Grob PJ; Hellwege HH; Schulz KH
    Dtsch Med Wochenschr; 1973 Mar; 98(9):415-20. PubMed ID: 4691560
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunodeficiencies in chronic muco-cutaneous candidosis.
    Lehner T; Wilton JM; Ivanyi L
    Immunology; 1972 May; 22(5):775-87. PubMed ID: 4336639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor.
    Froland SS; Natvig JB; Hoyeraal HM; Kåss E
    Scand J Immunol; 1974; 3(2):223-8. PubMed ID: 4207152
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
    Elliott ST; Hanifin JM
    Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed hypersensitivity in the mouse.
    Crowle AJ
    Adv Immunol; 1975; 20():197-264. PubMed ID: 47220
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
    Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
    Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human skin responses to products of concanavalin A-activated lymphocytes.
    Valdimarsson H; Gross NJ
    J Immunol; 1973 Aug; 111(2):485-91. PubMed ID: 4717991
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor.
    Irwin GR; Hierholzer WJ; Cimis R; McCollum RW
    J Infect Dis; 1974 Dec; 130(6):580-7. PubMed ID: 4610063
    [No Abstract]   [Full Text] [Related]  

  • 37. Photoallergy: a critical survey.
    Amos HE
    Trans St Johns Hosp Dermatol Soc; 1973; 59(2):147-51. PubMed ID: 4135964
    [No Abstract]   [Full Text] [Related]  

  • 38. Human cells required for macrophage migration inhibitory factor (MIF) production.
    Twomey JJ; Lazar S; Rocklin RE
    Clin Immunol Immunopathol; 1977 Nov; 8(3):396-404. PubMed ID: 334402
    [No Abstract]   [Full Text] [Related]  

  • 39. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
    Clausen JE
    Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological observations in chronic mucocutaneous candidiasis.
    Canales L; Middlemas RO; Louro JM; South MA
    Lancet; 1969 Sep; 2(7620):567-71. PubMed ID: 4185535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.